Drug duplicated to defame India Pharma co chief on WHO alert

DERA BASSI: After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, managing director, QP Pharma Chem Limited, Sudhir Pathak said someone had duplicated the syrup to defame the Government of India.

The WHO has issued a ‘WHO Medical Product Alert’ after “substandard (contaminated)” Guaifenesin Syrup TG Syrup was found in the Marshall Islands and Micronesia.

The manufacturer of the affected product is QP Pharma Chem Limited in Punjab, India.

The marketer of the product is Trillium Pharma in Haryana, said WHO.

“Food And Drug Administration (FDA) of Punjab doubt that someone has duplicated the product (cough syrup) sent to Cambodia and then sold it in the Marshall Islands and Micronesia to defame the Government of India,” said Sudhir Pathak, MD of the firm based in Dera Bassi, Punjab .

Pathak said that the FDA department had taken samples of cough syrup and were sent to Cambodia for testing.